// App-Quantinova.ai

POS0320 (2022) : EPIDEMIOLOGY AND HEALTHCARE RESOURCE UTILIZATION OF PATIENTS WITH EGPA IN THE UNITED KINGDOM

Researchers

Presenter

  • J. Hwee

Principal Investigators

  • Q. Fu

  • L. Harper

  • K. Nirantharakumar

  • R. Goel

  • R. Jakes

Medical Centers

  • GSK, Value Evidence Outcomes, Mississauga, Canada

  • GlaxoSmithKline, Value Evidence and Outcomes, Collegeville, PA, United States of America

  • University of Birmingham, Institute of Applied Health Research, United Kingdom

  • Oxon Epidemiolo- gy, London, United Kingdom

Locations

  • Canada

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Eosinophilic granulomatosis with polyangiitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • Biopharma (researcher initiated project)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved